Gastric Cancer
Gastric cancer, also known as stomach cancer, is a type of cancer that begins in the stomach lining and can spread to nearby tissues. It often presents with symptoms such as stomach pain, nausea, and weight loss.
Gastric Cancer: Pre-operative Treatment with Capecitabine and Atezolizumab
We are studying a combination of chemotherapy and immunotherapy for patients with resectable gastric and GE-junction cancer. The goal is to see if this treatment is safe and effective in shrinking tumors before surgery.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have a history of severe heart problems, such as a heart attack or unstable angina, in the last 3 months?
- Are you currently pregnant or breastfeeding, or planning to become pregnant during the study?
- Do you have any signs of cancer that has spread to other parts of your body?
- Are you taking any medications that suppress your immune system, like corticosteroids (e.g., Prednisone) or other immunosuppressive drugs?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Bendadocel
Camitotic
Capecel
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Gastroenterology
Amstelveen, Netherlands
Catharina Ziekenhuis Stichting
Surgery
Eindhoven, Netherlands
Sponsor: Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.